Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-04-03 Disposition | 2024-04-05 4:55 pm | N/A 2030-03-23 | Kinnate Biopharma Inc. | KNTE | Farzan Nima CHIEF EXECUTIVE OFFICER | 3,146,241 | $0 | 0 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:38 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-02-10 Option Award(A) | 2023-02-15 11:01 am | N/A 2033-02-10 | Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 5:00 pm | N/A 2033-02-10 | Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer | 750,000 | $0 | 215,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:24 pm | N/A 2032-05-31 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:00 pm | N/A 2032-02-11 | Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:29 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-16 5:54 pm | N/A 2031-02-12 | Kinnate Biopharma Inc. | KNTE | Farzan Nima Chief Executive Officer | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2020-12-02 9:14 pm | 2020-03-23 2030-03-23 | Kinnate Biopharma Inc. | KNTE | Farzan Nima President and CEO | 0 | $0 | 1,719,055 (Direct) | View |
| 2020-05-29 Option Award | 2020-05-29 5:19 pm | N/A 2030-05-29 | Keros Therapeutics Inc. | KROS | Farzan Nima Director | 8,500 | $0 | 8,500 (Direct) | View |